Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In Ayurveda, every individual is believed to possess a unique entity known as which distinguishes them from others physically, physiologically, and psychologically. This entity also determines an individual's response to a particular stimulus, and it is believed that such responses are not solely determined by genetics. The present research aims to validate the Ayurvedic concept of from a modern molecular perspective to strengthen the personalized and precise treatment approach. A study was conducted to investigate the role of the KCNJ11gene in the susceptibility of individuals to type 2 diabetes mellitus (T2DM) with their metabolic status. The research involved allele mining on three major groups - , and in 112 patients with T2DM and 112 healthy individuals. The KCNJ11 gene, responsible for insulin secretion membrane pore formation, was analyzed to determine the susceptibility of different types to T2DM. The MutPred tool predicted the molecular cause of disease-related amino acid substitution. According to the study, only and were diagnosed with diabetes, while all three types were present in the control group of healthy individuals. A protein model was prepared, and the changes resulting from mutations were observed for each group in their protein sequence, both as synonymous and non-synonymous mutations. Ultimately, these changes contributed to the manifestation of T2DM. Based on the findings, it appears that groups may experience changes in protein function due to nonsynonymous mutations and differences in amino acids at the protein level.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11384949PMC
http://dx.doi.org/10.1016/j.jtcme.2024.01.004DOI Listing

Publication Analysis

Top Keywords

kcnj11 gene
8
type diabetes
8
healthy individuals
8
molecular study
4
study kcnj11
4
gene correlation
4
correlation prakriti
4
prakriti preventing
4
preventing managing
4
managing type
4

Similar Publications

Introduction: Genetic analysis is essential for diagnosing, treating, and predicting complications in neonatal diabetes mellitus (NDM) but is unavailable in some regions. Sulfonylureas are effective for NDM caused by KCNJ11 or ABCC8 mutations, which are among the most common genetic causes, therefore they are often given before genetic testing. Unfortunately, in certain ethnicities, this mutation rarely occurs.

View Article and Find Full Text PDF

Background: Neonatal diabetes mellitus (NDM) is a rare monogenic disorder, typically diagnosed within the first six months of life. While NDM is well-recognized globally, data from India regarding its clinical characteristics, treatment strategies, and long-term outcomes are scarce.

Objectives: To describe the molecular characterization, clinical phenotype and follow-up of children with NDM.

View Article and Find Full Text PDF

Systematic Exploration of Potential Druggable Genes for Ischemic Stroke Employing Genome-Wide Mendelian Randomization Analysis.

Brain Behav

September 2025

Department of Thoracic Surgery II, Department of Lung Transplantation, Organ Transplantation Center, the First Hospital of Jilin University, Changchun, China.

Background: Ischemic stroke (IS) treatment remains a significant challenge. This study aimed to identify potential druggable genes for IS using a systematic druggable genome-wide Mendelian Randomization (MR) analysis.

Methods: Two-sample MR analysis was conducted to identify the causal association between potential druggable genes and IS.

View Article and Find Full Text PDF

Tailored Therapies for Hereditary Diabetes: Unraveling the Genetic Underpinnings of MODY and Neonatal Diabetes.

Curr Gene Ther

August 2025

Pharmacy, Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.

Introduction: Hereditary forms of diabetes, including Maturity-Onset Diabetes of the Young (MODY) and Neonatal Diabetes Mellitus (NDM), are rare monogenic disorders caused by mutations in genes involved in pancreatic development, beta-cell function, and insulin secretion. Unlike the polygenic nature of type 1 and type 2 diabetes, these forms provide a unique model for precision medicine.

Methods: A comprehensive literature review was conducted to explore the molecular genetics, clinical features, diagnostic advancements, and therapeutic strategies related to MODY and NDM.

View Article and Find Full Text PDF

: Heart failure with reduced ejection fraction (HFrEF) is associated with significant renal complications, affecting disease progression and patient outcomes. Sodium-glucose co-transporter-2 (SGLT2) inhibitors have emerged as a key therapeutic strategy, offering cardiovascular and renal benefits in these patients. However, interindividual variability in response to dapagliflozin underscores the role of pharmacogenetics in optimizing treatment efficacy.

View Article and Find Full Text PDF